Showing results (521-530 of 610) with videos related to
Sort By:
Pageof 61
Nature Communications|August 26, 2025
Peripheral blood DNA methylation predicts the early onset of primary tumor in TP53 mutation carriersVallijah Subasri, Benjamin Brew, Brianne Laverty, et al.BMJ Open|October 1, 2021
Implementation of serological and molecular tools to inform COVID-19 patient management: protocol for the GENCOV prospective cohort studyJennifer Taher, Chloe Mighton, Sunakshi Chowdhary, et al.Eclinicalmedicine|February 21, 2024
Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative dataAlberto Hernando-Calvo, Paul Nguyen, Philippe L Bedard, et al.Cancer Discovery|February 23, 2024
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid TumorsEric Y Stutheit-Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, et al.Nature Communications|April 3, 2024
Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironmentJie Li, Christopher R Chin, Hsia-Yuan Ying, et al.Nature Communications|August 30, 2024
FAM72A degrades UNG2 through the GID/CTLH complex to promote mutagenic repair during antibody maturationPhilip Barbulescu, Chetan K Chana, Matthew K Wong, et al.NPJ Precision Oncology|March 12, 2024
Biallelic EPCAM deletions induce tissue-specific DNA repair deficiency and cancer predispositionV J Forster, M Aronson, C Zhang, et al.Cancer Research Communications|June 28, 2023
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni SyndromeVallijah Subasri, Nicholas Light, Nisha Kanwar, et al.Genome Research|June 29, 2019
High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastomaMichael J Johnston, Ana Nikolic, Nicoletta Ninkovic, et al.Cell Metabolism|December 8, 2021
Coenzyme A fuels T cell anti-tumor immunityMichael St Paul, Samuel D Saibil, SeongJun Han, et al.Pageof 61